TEST

Because lung cancer is not a homogeneous disease...

for actionable mutations in mNSCLC

IDENTIFY

mNSCLC patients with BRAF V600 mutation

ACT

with TAFINLAR + MEKINIST to treat BRAF V600 mNSCLC

TAFINLAR Summary of Product Characteristics

MEKINIST Summary of Product Characteristics